Symbol="AGLE"
AssetType="Common Stock"
Name="Aeglea Bio Therapeutics Inc"
Description="Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapies for the treatment of patients and families with rare metabolic diseases. The company is headquartered in Austin, Texas."
CIK="1636282"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="901 S. MOPAC EXPRESSWAY, STE. 250, BARTON OAKS PLAZA ONE, AUSTIN, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="38663400"
EBITDA="-214439008"
PERatio="None"
PEGRatio="0"
BookValue="-2.56"
DividendPerShare="0"
DividendYield="0"
EPS="-0.82"
RevenuePerShareTTM="0.013"
ProfitMargin="0"
OperatingMarginTTM="-175.87"
ReturnOnAssetsTTM="-0.771"
ReturnOnEquityTTM="-1.633"
RevenueTTM="1228000"
GrossProfitTTM="-262000"
DilutedEPSTTM="-0.82"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.101"
AnalystTargetPrice="0.7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.084"
PriceToBookRatio="0.351"
EVToRevenue="1.265"
EVToEBITDA="0.535"
Beta="2.575"
num_52WeekHigh="1.56"
num_52WeekLow="0.106"
num_50DayMovingAverage="0.434"
num_200DayMovingAverage="0.456"
SharesOutstanding="78409000"
DividendDate="None"
ExDividendDate="None"
symbol="AGLE"
open="0.45"
high="0.51"
low="0.45"
price="0.49"
volume="277853.00"
latest_trading_day="2023-08-18"
previous_close="0.48"
change="0.01"
change_percent="2.7254%"
aroon_positive_momentum_days="41"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="41"
Volume_recent_avg="4468380"
Change_recent_avg="0.01"
Delta_recent_avg="0.04"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-1.97"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="41"
Aroon_momentum_negative="59"
image_negative_thumbnail_id_1="134"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0042.jpeg"
image_negative_thumbnail_id_2="119"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0057.jpeg"
image_neutral_thumbnail_id_1="588"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="651"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0057.jpeg"
image_positive_thumbnail_id_2="1000"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0162.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
